| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36777602P | 2002-03-25 | 2002-03-25 | |
| US36789302P | 2002-03-25 | 2002-03-25 | |
| US60/367,776 | 2002-03-25 | ||
| US60/367,893 | 2002-03-25 | ||
| PCT/US2003/009121WO2003083065A2 (en) | 2002-03-25 | 2003-03-25 | Improved methods for achieving expression from alphavirus vectors |
| Publication Number | Publication Date |
|---|---|
| AU2003222068A8 AU2003222068A8 (en) | 2003-10-13 |
| AU2003222068A1true AU2003222068A1 (en) | 2003-10-13 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003222068AAbandonedAU2003222068A1 (en) | 2002-03-25 | 2003-03-25 | Improved methods for achieving expression from alphavirus vectors |
| Country | Link |
|---|---|
| AU (1) | AU2003222068A1 (en) |
| WO (1) | WO2003083065A2 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60233061D1 (en) | 2001-09-06 | 2009-09-03 | Alphavax Inc | ALPHAVIRUS REPLICON VECTOR SYSTEMS |
| KR101518309B1 (en) | 2003-03-20 | 2015-05-08 | 알파벡스, 인크. | Improved alphavirus replicons and helper constructs |
| DK1651666T3 (en) | 2003-07-11 | 2009-08-31 | Alphavax Inc | Alphavirus-based cytomegalovirus vaccines |
| AU2005327198B2 (en) | 2004-07-09 | 2011-03-31 | University Of North Carolina At Chapel Hill | Viral adjuvants |
| EP1856250B1 (en) | 2005-02-15 | 2013-07-24 | The University of North Carolina At Chapel Hill | New live virus vaccines |
| ES2304880B1 (en)* | 2007-04-03 | 2009-10-27 | Proyecto De Biomedicina Cima, S.L. | USE OF A MUTED VIRAL VECTOR FOR THE IN VITRO GENERATION OF STABLE CELLULAR LINES. |
| ES2670813T3 (en) | 2007-06-21 | 2018-06-01 | Alphavax, Inc. | Alphavirus Replicon Particles for Vaccination Use |
| GB201310432D0 (en)* | 2013-06-12 | 2013-07-24 | Univ St Andrews | Virus Production |
| US10494421B2 (en) | 2014-02-10 | 2019-12-03 | Univercells Nv | System, apparatus and method for biomolecules production |
| WO2020056228A1 (en)* | 2018-09-14 | 2020-03-19 | Mayo Foundation For Medical Education And Research | Materials and methods for treatment with oncolytic viruses and modified car t cells |
| JP2022512912A (en)* | 2018-11-07 | 2022-02-07 | グリットストーン バイオ インコーポレイテッド | Alpha virus nascent antigen vector and interferon inhibitor |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6015686A (en)* | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
| Publication number | Publication date |
|---|---|
| AU2003222068A8 (en) | 2003-10-13 |
| WO2003083065A3 (en) | 2004-07-29 |
| WO2003083065A2 (en) | 2003-10-09 |
| Publication | Publication Date | Title |
|---|---|---|
| AU2002334717A1 (en) | Improved method for generating an aerosol | |
| AU2003221733A1 (en) | Improved raav vectors | |
| AU2003222544A1 (en) | Homing process | |
| AU2003286006A1 (en) | Cyclotron | |
| AU2002232187A1 (en) | Authenticating method | |
| AU2003237038A1 (en) | Adaptive rate matching method | |
| AU2003206898A1 (en) | Method for rate matching | |
| AU2003260951A1 (en) | Region restrictive playback system | |
| AU2003241332A1 (en) | Keymat | |
| AU2003301899A1 (en) | Member for producing castings | |
| AU2003258070A1 (en) | Electrodionization method | |
| AU2003222068A1 (en) | Improved methods for achieving expression from alphavirus vectors | |
| AU2003278355A1 (en) | Process | |
| AU2003301316A1 (en) | Improved immunotherapy | |
| AU2003299732A1 (en) | Vectors for inducible rna interference | |
| AU2002950473A0 (en) | Expression system | |
| AU2003229646A1 (en) | Authentication method | |
| AU2003271883A1 (en) | Vector system | |
| AU2003264722A1 (en) | Methods | |
| AU2003217765A1 (en) | System for hair removal | |
| AU2003253813A1 (en) | Method for colpoplasty | |
| AU2003253447A1 (en) | Expression vectors | |
| AU2003257434A1 (en) | L-amidase from rhizobium huautlense | |
| AU2003263197A1 (en) | Process | |
| AU2003242061A1 (en) | Method for fast frequency estimation by means of the rls method |
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |